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THE desirabilityoffindingaradioactive compound that would localize in tumor
tissue and which could be used in the diagnosis and therapy ofinternal cancer has
long been recognized. Previous studies carried out in our Laboratory have shown
that with certain sulfur 35-labeled derivatives of fluorene, localization in tumor
tissue is favorable compared to liver, kidneys, spleen, blood and muscle. The first
of these promising compounds was disodium fluorene-2,7-disulfonate-S35 (Argus,
1953). This compound was then used as the basis for the synthesis ofa number of
related substances which could be used for investigating the relation of chemical
structure to tumor localizing properties in the hope of obtaining compounds of
improved characteristics. Ofthose tested, sulfonatedfluorene-2,7-di-(sulfonamido-
2'-naphthalene)-S35 showed the best tumor localization. Two compounds without
free sulfonic acid groups, fluorene-2,7-disulfonamide-S35 and fluorene-2,7-di-
(sulfonamido-2'-naphthalene)-S35, did not selectively concentrate in tumor tissue
(Argus and Hewson, 1954). There seemed to be some indication at 8 hours,
however, that the latter compound showed a differential in the blood between
tumor-bearers and non-tumor-bearers. This difference was not large but if real
could be of considerable diagnostic importance since there was the possibility
that the effect could be enhanced in a new compound of suitable structure.
In the present study three new substances were investigated in tumor-bearing
and tumor-free mice. These were fluorene-2,7-di-(sulfonamidobenzene)-S35 (I),
a disulfonamido derivative of fluorene with molecular weight falling between the
compounds previously tested; and two related biphenyl derivatives, biphenyl-4,
4'-di-(sulfonamidobenzene-4-carboxylic acid)-S35 (II) and biphenyl-4,4'-di-(sul-
fonamidobenzene-S35-4-sulfonamide) (III).
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MATERIALS AND METHODS
Fluorene-2,7-disulfonyl chloride-S35.-The procedure described previously
(Argus and Hewson, 1954) was employed, but 40 millicuries of sulfur-35 were
used with the same quantities of other reactants. Recrystallization from toluene
gave a product melting 221-222°; specific activity was not determined on this
intermediate.
Fluorene-2,7-di-(sulfonamidobenzene)-S35 (J).-Finely powdered fluorene-2,7-
disulfonyl chloride-S35, 1-82 g. (0-005 moles), was slowly added to a solution of
freshly distilled aniline, 2-47 ml. (0-027 moles), in 35 ml. anhydrous benzene at
450. This mixture was stirred for 2 hours at 60-70° and for 1 hour additional.
The white precipitate was collected and washed free of aniline hydrochloride with
hot water. Two grams of product (83.7 per cent of theory) melting at 250-2550
were obtained. Following recrystallizationfrom 95 per cent ethanol, the compound
melted at 262-263° and had a specific activity of 17,000 disintegrations per second
per mg. Analyses gave 13-35 and 13-59 per cent S, 62-91 and 63-27 per cent C,
4-02 and 4-16 per cent H, and 5-54 and 5-47 per cent N; the calculated values
are 13-46 per cent S, 63-00 per cent C, 4-23 per cent H, and 5-88 per cent N.
Biphenyl-4,4'-disulfonyl chloride-S35.-Biphenyl, 7-7 g. (0.05 moles), was added
slowly with stirring to 16-3 ml. (0.25 moles) chlorosulfonic acid containing 20
millicuries sulfur-35. After the reaction mixture was agitated at room temperature
for 4 hours, the light gray precipitate was collected, washed free of acid with
cold water, and dried over phosphorus pentoxide, Two recrystallizations from
anhydrous benzene gave 5-3 g. (30.22 per cent theory) of white product melting
206-208'. Analyses gave 19-57 per cent Cl, and 18-25 and 18-34 per cent S;
the calculated values are 20-19 per cent Cl, and 18-26 per cent S.
Biphenyl-4,4'-di-(sulfonamidobenzene-4-carboxylic acid)-S35 (II).-Biphenyl-4,
4'-disulfonyl chloride-S35, 1-7 g. (0-005 moles), was finely powdered and slowly
added to a solution of p-aminobenzoic acid, 2-8 g. (0-020 moles), in 30 ml. anhy-
drous acetone. The mixture was stirred for 30 minutes at reflux temperature and
for 10 hours at room temperature. The light gray precipitate was collected,
washed with 750 ml. hot water and dried over phosphorus pentoxide. The yield
was 2-6 g. (82-6 per cent oftheory); the compound melted at 3200. Recrystalliza-
tion by dissolving in 70 ml. of a 2: 5 mixture of water: dimethylformamide and
precipitating with 30 ml. ofwater gave a white product melting at 3270 and having
a specific activity of 16,000 disintegrations per second per mg. Analyses gave
56-15 and 56-20 per cent C, 4-96 and 5-03 per cent N, and 11-26 and 11-28 per
cent S; the calculated values are 56-51 per cent C, 5-07 per cent N, and 11-61
per cent S.
Biphenyl-4,4'-di-(sulfonamidobenzene-S35-4-sulfonamide) (111).-Biphenyl-4,4'-
disulfonyl chloride-S35, 3 g. (0-0085 moles), dissolved in 35 ml. of anhydrous
acetone was added with stirring to a solution ofsulfanilamide, 7-35 g. (0-42 moles),
in 25 ml. anhydrous acetone at 500. The reaction mixture was stirred 1-5 hours
at 45-50° and 10 hours at room temperature. A white precipitate was formed by
slowly pouring the reaction solution into 400 ml. of water, with stirring. The
product was collected, washed with 750 ml. ofhot water, and air dried. This gave
5-2 g. (97-77 per cent oftheory) ofthe compound melting at 289-2900. Recrystal-
lization by dissolving in 70 ml. of a 2: 5 mixture of water: dimethylformamide
and precipitating with 30 ml. of water resulted in a product melting at 2950
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and having a specific activity of 9700 disintegrations per second per mg. Analyses
gave 46-59 per cent C, 9-18 and 9-23 per cent N, and 20-93 per cent S; the cal-
culated values are 46-29 per cent C, 9 00 per cent N, and 20-60 per cent S.
Animal experiments
Male CAF,/Jax hybrid mice were employed in this study. The distribution
of the three sulfur 35-labeled disulfonamides was studied in 70 mice (Tables I
and III) when the animals were 8 weeks old. Four weeks prior to administration
of the compounds, 34 of the mice received a subaxillary transplant of a keratiniz-
ing squamous cell carcinoma (Line A, stomach carcinomata originally obtained
from the Animal Supply and Research Units of the British Empire Cancer Cam-
paign) now in its 83rd generation transplant in our laboratory.
Biphenyl-4,4'-di-(sulfonamidobenzene-S35-4-sulfonamide) (III) was studied
in 8 additional animals: 2 mice 4-5 weeks old with 4-day-old tumor transplant,
2 mice 7 weeks old with 3-week-old tumor transplant, 2 mice 8-5 weeks old from
which a 4-week-old tumorhad been excised 3 days prior to receiving the compound,
and 2 mice 11 weeks old from which a 4-week-old tumor had been removed 3
weeks prior to the study (Table V). Four other mice were pylorus-ligated accord-
ing to the method previously described (Klein, Argus, and Ray, 1953) prior to
receiving biphenyl-4,4'-di-(sulfonamidobenzene-4-carboxylic acid)-S35 (II).
The sulfur 35-labeled compounds were administered by tail vein in the follow-
ing amounts per mouse: fluorene-2,7-di-(sulfonamidobenzene)-S35 (I), 3 mg.
in 0-5 ml. of 0-05 N sodium hydroxide; biphenyl-4,4'-di-(sulfonamidobenzene-
4-carboxylic acid)-S35 (II), 4 mg. in 0-5 ml. of 0 05 N sodium bicarbonate; and
biphenyl-4,4'-di-(sulfonamidobenzene-S35-4-sulfonamide) (III), 4 mg. in 0*5 ml.
of 0 05 N sodium bicarbonate. Animals were sacrificed at 2-, 8-, 16-, and 32-hour
intervals following treatment, and pooled samples from 2 animals were used for
each determination. Just prior to sacrifice, the mice were anesthetized with
nembutal, and blood was removed by heart puncture using a heparinized syringe.
The blood was centrifuged to separate plasma and cells. Plasma was plated
using 0 4 ml. plasma plus 0-6 ml. 1 per cent sodium hydroxide per planchet. The
cells were washed twice with saline and planchets were plated with 0*3 ml. cells
plus 0-7 ml. 1 per cent sodium hydroxide. The tissues to be studied were removed,
weighed immediately and placed in 10 ml. of 1 per cent sodium hydroxide (con-
taining 1 ml. of Tergitol wetting agent per 250 ml.) per gram of tissue. Excreta
were suspended in sufficient water to bring the total volume to 100 ml., and 20 ml.
of 5 per cent sodium hydroxide was added to this. After storing at 50 for 48 hours,
the tissues were solubilized by autoclaving at 15 lb. for 30 minutes and a 1 ml.
aliquot ofeach was plated on a stainless steel planchet.
Radioactivity measurements were made with a Nuclear-Chicago, Model D-47,
thin window, Q-gas counting chamber with Model C-I10 automatic sample changer
and Model 183 scaler. The efficiency was 20 per cent and duplicate sample counts
were within 3 per cent. The concentration of the sulfur 35-labeled disulfonamides
in each sample was determined by direct comparison with standard planchets
prepared in the same manner and containing known concentrations of the radio-
active compounds. To eliminate correction for the decay ofsulfuW35, the standards
were counted the same day as the samples. Total blood volume was calculated
on the basis of 63-2 ml. per kg. body weight (Oakley and Warrack, 1940).DISTRIBUTION OF LABELED DISULFONAMIDES IN MICE
RESULTS AND DISCUSSION
The distribution of radioactivity in tumor-bearing and tumor-free CAF,/Jax
mice following intravenous injection of fluorene-2,7-di-(sulfonamidobenzene)-S35
(I) is given in Table I. These data show that 2 hours after administration, the
concentration of compound in the tumor is less than in any other tissue. At
8 hours, however, the concentration of radioactivity decreases in all normal
tissues except the largeintestine, but the valuefortheneoplasm remains essentially
the same as the 2-hour value. The concentration of radioactivity in the tumor
at 8 hours exceeds that in blood cells and plasma, spleen, kidneys, muscle and
carcass. The level of radioactivity in the gastrointestinal tract is high at all
time intervals studied. The ratios ofthe concentration of this compound in tumor
tissue to that in the blood, vital organs, skin, muscle and carcass are tabulated
in Table II. Values greater than unity indicate favorable tumor localization.
TABLE I.-Distribution of Radioactivity in Mice at Different Time Intervals
Following Intravenous Injection of Fluorene-2,7-di-(sulfonamidobenzene)-S35
Tumor-bearing animals:
Blood cells.
Blood plasma
Liver
Lungs
Spleen
Kidney
Skin
Leg muscle
Stomach plus contents
Small intestine plus contents
Large intestine plus contents
Carcass
Excreta
Tumor .
Total
Tumor-free animals:
Blood cells.
Blood plasma
Liver
Lungs
Spleen
Kidney
Skin
Leg muscle
Stomach plus contents
Small intestine plus contents
Large intestine plus contents
Carcass
ExCreta
Total
Concentration in ,tg. compound
per g. tissue, or ml. blood
cells, or plasma
2 hr.* 8 hr.t 16hr.1 32hr.T
37 4 2 0 3 02 . 092
107 7.5 2 2 1.1 265
325 131 5 53.5 29-3 . 14 98
125 51 5 21*5 13*5 . 047
56 21 5 82 6 3 036
105 25-5 10-7 7.5 . 116
76 56 0 12 0 16 7 . 972
63 19.0 6-0 4 0 . 0*29
137 64 0 20 0 50-0 . 0-95
470 173-0 5850 70 0 . 2186
880 2705 0 1513*0 600 5 484
52 12 0 6 8 4 0 . 21 10
3-67
36 35 5 28-8 18-2 . 0-33
- - - 583 30
46-0 5*0 0-3 0-3 1-06
155-5 6-0 2-7 20 354
273-5 118-0 59.7 33-0 12-69
130-5 15-5 19-2 13-2 . 0-55
70 0 11-5 10-5 7-0 . 0-49
115-0 16-0 14-0 9.5 1-30
102-0 37-0 18-7 11-2 . 13-01 94.5 10-5 6-3 4.3 . 0-50 85.0 203-0 40 0 90-0 0-96
510 0 145-0 73-0 112-0 . 25-40
435 0 1887-5 1868-0 760-0 13-71
60-5 7.5 9-2 6-8 . 23-20
-_- - - . 3-32
- - - - 99.73
Percentage administered
radioactivity recovered
2 hr.* 8 hr.t 16hr.t 32hr.I
0o09
0-15
4 41
0-18
0-11
0 25
6-21
0-10
0 36
6 86
54 73
3 82
8 34
0 24
85 85
0-13
0-17
5-24
0-07
0-37
0-21
5 27
0-06
1-87
7 28
53 84
3 19
7 43
85. 13
* Average value from 2 animals.
t Average value from 4 animals.
I Average value from 6 animals.
0-81
5*91
2 70
0-11
0-06
0-14
1 67
0 05
0-13
2 68
41 81
2-90
24 28
0 35
83 60
0-66
5 93
2-14
0-08
0-03
0-15
2-07
0-04
0-22
2- 85
43 13
3-23
15-55
76-08
0-45
2 50
1-23
0-07
0-03
0 08
1 84
0 03
0-28
2 98
13-03
1-32
45 00
0-23
69-07
0-72
4 81
1-27
0-05
0-02
0-10
1-14
0-04
0-68
4 85
15-00
2-39
45- 11
76- 18
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TABLE II.-Ratios of the Concentration of Radioactiity in Tumor Tissue to the
Concentration in Other Tissues Following a Single Injection of Fluorene-2,7-di-
(sulfonamidobenzene)-S35 to Tumor-bearing Mice*
Time interval
following injection
2hr. 8hr. 16hr. 32hr.
Blood cells . . 0 97 7.45 96-00 91 00
Blood plasma . . 0 34 4- 73 13.10 16- 55
Liver . . . 011 0 27 0 54 0- 62
Lungs. . . 0-29 0 69 1-34 1 35
Spleen 0-64 1-65 3-51 2-89
Kidney . . 0 34 139 2-69 2-43
Skin . . . 0 47 0 63 2 38 1-09
Leg muscle . . 0 57 1 87 4- 80 4- 55
Carcass . . 0-69 2 96 4-24 4- 55
* A ratio greater than unity is favorable.
Thus, after 16 hours there is an increase in ratio in every case over the 8-hour
values. Only the liver localizes the compound to a greater extent than does the
tumor. At 32 hours the tumor still concentrates more of the radioactive material
than do the other tissues with the exception ofthe liver. One can conclude, for this
compound, that except for the liver the localization by tumor tissue compares
favorably with that of disodium fluorene-2,7-disulfonate-S35. The latter gives a
larger ratio for the liver, but concentrates more in the kidneys and gastrointestinal
tract than in neoplastic tissue (Argus, 1953). Another sulfonated compound of
this type, fluorene-2,7-di-(sulfonamido-S35-2'-naphthalene-X-sulfonic acid) shows
a greater localization in tumor tissue at 32 hours than in any other tissue studied
(Argus and Hewson, 1954). Thus, the introduction of sulfonic acid groups into
the molecule seems to enhance tumor affinity. The possibility that sulfonation
might increase the activity of compound I will be studied in a later phase of these
investigations.
InTable IIIissummarized the distribution of radioactivity following adminis-
tration of the two disulfonamido derivatives of biphenyl. The compound having
two free carboxy groups, biphenyl-4,4'-di-(sulfonamidobenzene-4-carboxylic
acid)-S35 (II), localizes in tumor tissue to a greater extent than in blood cells,
spleen, and leg muscle at 2 hours. The concentration in the tumor at 8 hours
is the same or greater than that in all other tissues, except the gastrointestinal
tract. The high level ofthis compound in the stomach contents, 2 hours following
intravenous injection, suggested possible secretion by the stomach wall. To
investigate this, four pylorus-ligated mice were injected intravenously with sulfur
35-labeled compound. For two animals sacrificed at 2 hours, the average recovery
of radioactivity from the stomach contents is 0.75 per cent of the administered
dose. At 8 hours the average recovery is 2*13 per cent. This secretion of a highly
acid compound is not in agreement with the results of Ingraham and Visscher
(1935) on the gastric secretion of dyestuffs. These authors found that only basic
dyes are secreted bythe gastric glands ofthe dog. Previous workinthislaboratory,
however, has indicated that an acid dye can be secreted by the rat stomach
(Cambel, Breidenbach and Ray, 1954).
Biphenyl-4,4'-di-(sulfonamidobenzene-S35-4-sulfonamide) (III) does not show
selective tumor affinity. Thus, all body constituents except the blood plasma,DISTRIBUTION OF LABELED DISULFONAMIDES IN MICE
TABLE III.-Distribution ofRadioactivity in Mice Following Intravenous Injection
ofDisulfonamido Derivative8 ofBiphenyl
Tumor-bearing animals:
Blood cells
Blood plasma
Liver
Lungs
Spleen
Kidney.
Skin
Leg muscle
Stomach plus con-
tents
Small intestine plus
contents
Large intestine plus
contents
Carcass .
Exereta
Tumor
Total
Concentration in ug. compound
per g. tissue, or ml. blood cells,
or plasma*
A. k
Compound Ilt Compound III:
2hr. 8hr. 2hr. 8hr.
<10-0
38-5
82-5
41-5
9-0
42-5
102-5
14-0
308-0
<10-0
10-0
17-5
13-0
3-0
9-0
10-0
0-0
41-5
1129-0 89-0
1405-0 2410-0
94-0
268-0
450-0
254.0
62-0
644-0
238-0
58-0
155-0
33-0
20-0
82-0
72-0
15-0
76-0
28-0
10-0
296-0
492-0 252-0
510-0 2050-0
36-5 10-0 95-0 18-0 . 14-04
- - - - 15-22
30-0 17-5 60-0 25-0 . 0-49
- - - - 90-59
Percentage administered
radioactivity recovered*
,~~~~~~~~~~~li-
Compound IIt
e
Compound I1$
. -
2hr. 8hr. 2hr. 8hr.
<0-001
0-84
2-44
0-08
0-04
0-30
0-22
0-04
1-54
<0-001
0-23
0-48
0-03
0-01
0-06
0-03
0-00
0-18
1-44
6-16
14-34
0-67
0-28
4-98
0-68
0-24
0-92
0-44
0-42
2-25
019
0-06
0-50
0-05
0-04
1-20
33-76 2-44 19-92 11-48
21-58 35-73 10-44 36-50
3-94
35-57
0-38
79-08
37-82
6-40
0-41
104-70
5-84
28-40
0-16
87-53
Tumor-free animals:
Blood cells
Blood plasma
Liver
Lungs
Spleen
Kidney .
Skin
Leg muscle
Stomach plus con-
tents
Small intestine plus
contents
Large intestine plus
contents
Carcass .
Exereta
Total
<10-0
39-5
97-5
85-5
10-0
46-5
110-0
16-5
274-0
<10-0
10-5
12-5
46-5
4-0
8-0
12-5
0-0
54-0
112-0
370-0
402-0
411-0
128-0
1022-0
298-0
88-0
142-0
40-0
106-0
142-0
74-0
35-0
572-0
100-0
22-0
78-0
<0-001
0-84
2-56
0-22
0-02
0-36
0-24
0-06
1-27
844-0 114-0 361-0 345-0 . 26-60
1000-0 2085-0 235-0 1734-0 . 20-94
28-0 11-5 128-0 42-0 . 11-18
-- - - 12-41
- - - - 76-70
* Each value is the average from 4 animals.
t Biphenyl-4,4'-di-(sulfonamidobenzene-4-carboxylic acid)-S35.
I Biphenyl-4,4'-di-(sulfonamifobenzene-S35-4-sulfonamide).
'<0-001
0-24
0-34
0-14
0-01
0-06
0-03
0-00
0-22
1-55
7-79
11-44
1-33
0-28
7-06
0-80
0-34
1-06
0-45
1-86
3-27
0-18
0-04
4-01
0-16
0-08
0-33
3-16 16-24 13-96
41-22 5-04 32-48
4-80
23-45
73- 67
46-60
5-18
104-71
13-18
29-62
99-62
spleen, leg muscle and carcass concentrate more radioactive material at 8 hours
than does thetumor (TableIII). Inprevious studies, anothercompoundthatfailed
to localize in tumor tissue, fluorene-2,7-di-(sulfonamido-2'-naphthalene)-S35,
did concentrate in the liver and spleen of tumor-free CAF,/Jax mice to a greater
extent than in these organs of mice bearing a transplanted squamous cell tumor;
(Argus and Hewson, 1954). The possible value of this phenomenon in cancer*
diagnosis led to more extensive studies which showed that difference in uptake of
46
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this compound exists also in other strains and species ofanimals, and with various
types oftransplanted tumors (Argus, Hewson and Ray, 1956; Argus, Lemasters,
Gutierrez andRay, 1957; andArgus, Seepe, KaneandRay, 1958). Sincebiphenyl-
4,4'-di-(sulfonamidobenzene-S35-4-sulfonamide) (III) did not show selective tumor
localization, differences in the uptake of this compound by the tissues of tumor-
free and tumor-bearing mice were investigated.
The ratios of the concentration of radioactivity in the liver, spleen, kidneys
andbloodplasma oftumor-free mice to the concentration inthesetissues oftumor-
bearing mice following administration of biphenyl-4,4'-di-(sulfonamidobenzene-
S35-4-sulfonamide) (III) are given in Table IV. The liver of tumor-free mice
TABLE IV.-Ratios of Concentration of Radioactivity in the Tissues of Tumor-free
Mice to the Concentration in Tissues of Tumor-Bearing Mice at 2 and 8 hours
following Intravenous Injection of Biphenyl-4,4'-di-(sulfonamidobenzene-835-
4-sulfonamide)
Ratio*
2hr. 8 hr.
Liver . . 0-89 1-73
Spleen . . 2-06 2-33
Kidneys . . . 1-59 7.53
Blood plasma 1-38 5-30
Concentration in tissue oftumor-free mice
Concentration in tissue oftumor-bearing mice )
Concentration is expressed as pg. compound/g. of tissue or ml. blood plasma; each concentration
value is the average from 4 animals.
localizes this compound in greater concentration than does the liver of tumor-
bearing mice at 8 hours, but not at 2 hours. The phenomenon is present for the
spleen at both time intervals studied. At 8 hours this ratio for the liver is about
the same as for fluorene-2,7-di-(sulfonamido-2'-naphthalene)-S35 in CAF1/Jax
mice; the ratio ofthe spleen is, however, less than that for the fluorene derivative
(Argus, Hewson and Ray, 1956).
With biphenyl-4,4'-di-(sulfonamidobenzene-S35-4-sulfonamide) (III) there are
two features not found with previous compounds. These are the large differences
in localization in the kidneys and in the blood plasma of tumor-free and tumor-
bearing animals. Thus, at 8 hours- the kidneys of control animals localize 7-53
times as much radioactive material as do the kidneys of tumor-bearing animals
(Table IV). This difference in the level ofcompound in the kidneys is not reflected
in the rate of excretion (Table III), since the percentage of administered dose
recovered from the exereta is approximately equal for tumor-free and tumor-
bearing animals at 2 and at 8 hours.
Two hours afterintravenous injection ofbiphenyl-4,4'-di-(sulfonamidobenzene-
S35-4'sulfonamide) (III) the concentration of radioactivity in the blood plasma
of tumor-free mice is 1-38 times that in the plasma of tumor-bearing mice. At 8
hourS the ratio increases to 5-30. Since the difference is measurable in a readily
accessible body fluid, this phenomenon may have greater promise as a diagnostic
tool. Further studies were therefore carried out at different times following
tumortransplantion and tumorexcision. The ratios obtained for the blood plasma
2hours afteradministration ofthe biphenyl compoundareshowninTable V. FourDISTRIBUTION OF LABELED DISULFONAMIDES IN MICE
TABLE V.-Concentration of Biphenyl-4,4'-di-(sulfonamidobenzene-835-4-sulfon-
amide)in theBloodPlasmaof Tumor-free, Tumor-bearing, and Tumour-excised
CAF1/Jax Mice 2 hours after Intravenous Injection
Mice Concentration* Ratiot
Tumor-free . . . 370 . 1O00
Bearing tumor 4 days . . 354§ . 105
Bearing tumor 3 weeks . 290§ . 128
Bearing tumor 4 weeks . . 268 . 138
Three days after tumor excision¶ . 231§ 160
Three weeks after tumor excision¶ . 330§ . 1-12
* jg. compound/ml. plasma.
t ( Concentration in tumor-free plasma
VConcentration in tumor-bearing plasma]
t Average value from 4 animals.
§ Average value from 2 animals.
1 Tumor excised 4 weeks after transplantation.
days after transplantation a slight increase in the ratio is noted; at 3 weeks the
ratio increases to 1V28; at 4 weeks the ratio is 1F38. Tumor excisions were made
at 4 weeks following transplantation; no metastases had occurred prior to
excision ofthe tumor. The ratio is still high (1.60) 3 days afterexcision, indicating
that the animals have not yet begun to return to normal; by 3 weeks the ratio
drops to 1*12. These ratios indicate that the capacity of blood plasma to concen-
tratethisbiphenyldisulfonamide isinfluencedbythepresenceorabsenceofatumor
in the animal body.
In conclusion, previous and present studies on this subject indicate that at
least two factors are important for tumor localization: (a) an optimum size of
the molecule, and (b) the presence of strong acidic groups. Thus, of fluorene-2,
7-disulfonamide-S35, fluorene-2,7-di-(sulfonamidobenzene)-S35, and fluorene-2,7-
di-(sulfonamido-2'-naphthalene)-S35, only fluorene-2,7-di-(sulfonamidobenzene)-
S35, the compound ofintermediate size, shows selective tumor localization. How-
ever, by introducing sulfonic acid groups into the naphthalene moiety offluorene-
2,7-di-(sulfonamido-2'-naphthalene)-S35, the compound acquires tumor affinity,
Similarly fluorene-2,7-disulfonic acid-S35 shows selective localization. This
enhancing ability ofacidic groups in the molecule is also evident in comparing the
tumor localization of the two derivatives of biphenyl investigated here. Thus,
biphenyl-4,4'-di-(sulfonamidobenzene-4-carboxylic acid)-S35 shows higher tumor
localization ratios than biphenyl-4,4'-di-(sulfonamidobenzene-S35-4-sulfonamide).
Whilestudies withfluorene-2,7-di-(sulfonamido-2'-naphthalene)-S35haveshown
that the presence of a tumor in the animal body affects the ability of the
spleen and liver to localize the compound, the present workwithbiphenyl-4,4'-di-
(sulfonamidobenzene-S35-4-sulfonamide) suggests that the presence of a neoplasm
also may influence the ability of the blood and kidneys to concentrate certain
large molecular weight compounds. What seems to be of importance, from the
diagnostic standpoint, is that a difference in the localizing ability of a tissue in
tumor-free andtumor-bearing animalshasbeendemonstratedinareadilyaccessible
body constituent.
SUMMARY
1. Syntheses are described for fluorene-2,7-di-(sulfonamidobenzene)-S35,
biphenyl-4,4'-disulfonyl chloride-S35, biphenyl-4,4'-di-(sulfonamidobenzene-4-
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carboxylic acid)-S35 and biphenyl-4,4'-di-(sulfonamidobenzene-S35-4-sulfonamide).
2. The distribution of radioactivity in tumor-bearing and tumor-free mice
following intravenous injection of the three disulfonamides showed fluorene-2,7-
di-(sulfonamidobenzene)-S35 to have the most favorable tumor localization.
3. Experiments with biphenyl-4,4'-di-(sulfonamidobenzene-4-carboxylic acid)-
S35inpylorus-ligated micerevealedthisacidcompoundto besecreted bythegastric
mucosa.
4. Biphenyl-4,4'-di-(sulfonamidobenzene-S35-4-sulfonamide) is concentrated by
the liver, spleen, kidneys and blood plasma oftumor-free mice to a greater extent
than by these organs oftumor-bearing mice, thus revealing diagnostic possibilities.
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